Thrombolytic Therapy for Ischemic Stroke
- 1 March 2000
- journal article
- editorial
- Published by American Medical Association (AMA)
- Vol. 283 (9) , 1189-91
- https://doi.org/10.1001/jama.283.9.1189
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Case report Cerebral hemorrhage after systemic fibrinolysis in a patient with severe carotid artery stenosisActa Neurologica Scandinavica, 2009
- Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience.Journal of Neurosurgical Anesthesiology, 2000
- Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom OnsetJAMA, 1999
- Does the National Institutes of Health Stroke Scale Favor Left Hemisphere Strokes?Stroke, 1999
- Yield of Transcranial Doppler in Acute Cerebral IschemiaStroke, 1999
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Are More Complex Study Designs Needed for Future Acute Stroke Trials?Cerebrovascular Diseases, 1998
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.Stroke, 1992
- 'Spectacular shrinking deficit'Neurology, 1992